Navigation Links
Swann in Medical News

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20 in New York. Dr. Hung will pr...

Genomic Health to Participate in Leerink Swann Roundtable Conference

REDWOOD CITY, Calif., March 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that Steven Shak, M.D., Genomic Health's Chief Medical Officer, will participate in Leerink Swann's Roundtable Conference, Bugs and Drugs: The Future of Molecular Diagnostics, in New ...

Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Leerink Swann "Bugs and Drugs: The Future of Molecular Diagnostics Roundtable Conference" in New York on April 3, 2008 at approximately 1:20 p.m. Eastern T...

BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference

FRANKLIN LAKES, N.J., March 26 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it would present at the Leerink Swann Molecular Diagnostics Roundtable Conference on Thursday, April 3, 2008 at 10:10 a.m. (ET). ...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...bject to satisfaction of customary closing conditions. Deutsche Bank Securities Inc. is acting as Sole Book-Running Manager for the offering. Leerink swann LLC is acting as Co-Lead Manager and Wedbush PacGrow Life Sciences is acting as Co-Manager. MAP Pharmaceuticals has filed a registration statem...

Orexigen(R) Therapeutics Prices Public Offering of Common Stock

...isfaction of customary closing conditions. Leerink swann LLC is acting as sole book-running manager for the...hich may be obtained, when available, from Leerink swann LLC , Attention: Syndicate Department, One Federal..., 37th Fl., Boston, MA 02110 or by calling Leerink swann LLC, toll free, at 1-800-808-7525, Ext. 4814. ...

Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock

... the shares are being offered by Orexigen. Leerink swann LLC is acting as sole book-running manager for the...ting to this offering may be obtained from Leerink swann LLC , Attention: Syndicate Department, One Federal..., 37th Fl., Boston, MA 02110 or by calling Leerink swann LLC, toll free, at 1-800-808-7525, Ext. 4814. ...

Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes

... Bank, Goldman, Sachs & Co. and Banc of America Securities LLC will act as joint book-running managers for the offering. Canaccord Adams, Leerink swann and Stifel Nicolaus will serve as co-managers. The offering will be made under Inverness' shelf registration statement on Form S-3 filed with the...

Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television

... Interviews With Board Member Lynn swann Appear On 'Fox & Friends,' 'NY1,' 'TheStreet.c...ed during recent interviews with Board Member Lynn swann on "Fox & Friends," "NY1," "TheStreet.com," an...rview with Gregg Greenberg of "TheStreet.com," Mr. swann discusses his involvement on the board of the Comp...

Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation

... business, other intangibles, inventories and fixed assets. The closing of the transaction is subject to customary closing conditions. Leerink swann LLC acted as exclusive financial advisor and delivered an opinion to the board of Alsius as to the fairness of the transaction. William Worthen...
Swann in Medical Technology

Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 3, 2007 - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection Company(TM), announced today the publication of new preclinical data from additional confirmatory animal studies showing that Allon's product candidate AL-108 significantly reduces th...

Light Sciences Oncology Raises $40.1 Million in Series C Financing

...d with our substantial cash reserves will allow us to continue to move forward with all aspects of our development plan in a timely manner." Leerink swann LLC acted as exclusive placement agent and exclusive financial advisor in connection with the transaction. About Light Sciences Oncology Light Sci...
Swann in Biological Technology

Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference

SOUTH SAN FRANCISCO, Calif., May 13 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presid...

Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference

HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on Frida...

Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference

WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Con...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...ge Commission a prospectus supplement with respect to the offering. Leerink swann LLC is acting as sole book-running manager for the offering. This a... and accompanying prospectus may be obtained, when available, from Leerink swann LLC, Attention: Syndicate Department, One Federal Street, 37(th) Floor, Bos...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

...issions and estimated expenses). Leerink swann LLC acted as sole book-running manager for the off...ctus, copies of which may be obtained from Leerink swann LLC , Attention: Syndicate Department, One Federal..., 37th Fl., Boston, MA 02110 or by calling Leerink swann LLC, toll free, at 1-800-808-7525, Ext. 4814. ...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

...ET Deutsche Bank Securities 34th Annual Healthcare Conference InterContinental Boston Tuesday, May 19, 2009 4:35 p.m. ET Leerink swann Novel Cancer Therapeutics: Oncology Roundtable The Roosevelt Hotel, New York City Wednesday, May 20, 2009 10:30 a.m. ET The presen...

Dendreon Reports First Quarter 2009 Financial Results

...ca / Merrill Lynch 2009 Health Care Conference on May 12, 2009 Deutsche Bank 34th Annual Healthcare Conference on May 19, 2009 Leerink swann Novel Cancer Therapeutics: Roundtable Conference on May 20, 2009 About Dendreon Dendreon Corporation is a biotechnology comp...

Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

...ng in gross proceeds of approximately $45.5 million to Pharmasset, before deducting the placement agent's fee and estimated offering expenses. Leerink swann LLC served as sole placement agent for the offering. Trout Capital provided advisory services for the offering. The shares described above are be...

Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering

...or about July 21, 2008, subject to satisfaction of customary closing conditions. Lazard Capital Markets LLC served as lead placement agent and Leerink swann LLC served as co-placement agent for the offering. Jazz Pharmaceuticals intends to use the net proceeds from this offering primarily to fund commerc...
Other Tags
(Date:8/30/2014)... (PRWEB) August 30, 2014 Daily Gossip reveals ... the Make Him Desire You program, who shows a unique ... The author of this method says that the program goes ... The Make Him Desire You review indicates that the program ... insider advice and his great techniques to make a man ...
(Date:8/30/2014)... Albany, New York (PRWEB) August 30, 2014 ... a combination of Nutrition and Pharameuticals. Nutraceuticals is ... by extracting healthy ingredients from natural food sources. ... specific health benefits to the human body. Nutraceutical ... multivitamins, diet supplements, fortified foods and more. Although ...
(Date:8/30/2014)... Tenn. (PRWEB) August 30, 2014 ... around the country for the past several years, ... Tennessee Hyperbaric Center have announced a scholarship program ... This announcement follows a meeting held this summer ... In recent years, reporters have shed light on ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... other incretin mimetic claims continue to move forward in ... statement issued by AstraZeneca PLC on July 31, 2014, ... been named in 409 product liability claims that allege ... Court documents indicate that many of these claims are ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has become ... apnea (a medical problem where the airway collapses during sleep ... the rest they need to face their daily challenges. ... million people in the United States alone have sleep apnea. ... of those treated, many cannot tolerate their prescribed medical device ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
(Date:8/28/2014)... traditional cigarettes, but still release toxins into the ... , Scientists studying secondhand smoke from e-cigarettes discovered ... particles, with close-to-zero exposure to organic carcinogens. However, ... second-hand e-cigarette smoke were found to be significantly ... of polycyclic aromatic hydrocarbons cancer-causing organic compounds ...
(Date:8/28/2014)... and his collaborators have developed an online analytic tool ... re-engineering cells for biomedical investigation. CellNet is a free-use ... stem cell engineering. Details of CellNet and its application ... papers in the journal Cell . , "This ... all types of cell-based investigations and can potentially offer ...
(Date:8/28/2014)... MD FASEB MARC (Maximizing Access to Research ... for the Genetics Society of America,s 27th Annual ... October 3, 2014 in Pacific Grove, California. ... of students, post doctorates and scientists from underrepresented ... community and to encourage the participation of young ...
Breaking Biology News(10 mins):Second-hand e-cig smoke compared to regular cigarette smoke 2New tool aids stem cell engineering for medical research 2
Other Contents